- Home
- CLRB vs OPI Comparison
CLRB vs OPI Comparison
Compare CLRB & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- OPI
- Stock Information
- Founded
- CLRB 2002
- OPI 2009
- Country
- CLRB United States
- OPI United States
- Employees
- CLRB N/A
- OPI N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- OPI Real Estate Investment Trusts
- Sector
- CLRB Health Care
- OPI Real Estate
- Exchange
- CLRB Nasdaq
- OPI Nasdaq
- Market Cap
- CLRB 14.2M
- OPI 16.6M
- IPO Year
- CLRB N/A
- OPI 2009
- Fundamental
- Price
- CLRB $4.44
- OPI $0.24
- Analyst Decision
- CLRB Hold
- OPI
- Analyst Count
- CLRB 2
- OPI 0
- Target Price
- CLRB N/A
- OPI N/A
- AVG Volume (30 Days)
- CLRB 113.2K
- OPI 924.2K
- Earning Date
- CLRB 08-14-2025
- OPI 07-30-2025
- Dividend Yield
- CLRB N/A
- OPI 16.92%
- EPS Growth
- CLRB N/A
- OPI N/A
- EPS
- CLRB N/A
- OPI N/A
- Revenue
- CLRB N/A
- OPI $466,972,000.00
- Revenue This Year
- CLRB N/A
- OPI N/A
- Revenue Next Year
- CLRB N/A
- OPI N/A
- P/E Ratio
- CLRB N/A
- OPI N/A
- Revenue Growth
- CLRB N/A
- OPI N/A
- 52 Week Low
- CLRB $4.36
- OPI $0.18
- 52 Week High
- CLRB $68.70
- OPI $2.48
- Technical
- Relative Strength Index (RSI)
- CLRB 35.40
- OPI 46.17
- Support Level
- CLRB $4.72
- OPI $0.23
- Resistance Level
- CLRB $5.09
- OPI $0.25
- Average True Range (ATR)
- CLRB 0.38
- OPI 0.03
- MACD
- CLRB 0.09
- OPI -0.00
- Stochastic Oscillator
- CLRB 3.42
- OPI 15.00
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.